Tag Archives: BIO International Convention

Convention Attendees Make the Call on Expanded Access

Bioethics Panel

The BIO International Convention kicked off Monday with an interactive session organized by the BIO Board Standing Committee on Bioethics: The Bioethics of Drug Development—You Make the Call. Attendees engaged in a real-time polling exercise addressing the many difficult issues related to expanded access using a mock case study of a company – iCures – dealing with an expanded access request. Moderator Steve Usdin, Senior Editor, BioCentury, led the panel through challenging issues in drug Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Seek and Destroy

shutterstock_27160801

Ubiquibodies combine the specificity of antibodies with the destruction signal of ubiquitinization. Stand by for targeted destruction of disease-causing proteins in the cell Proteins in a cell that are aged or otherwise damaged are recycled via the ubiquitin-proteasome pathway (UPP). The doomed protein is first tagged with a protein called ubiquitin, which acts like a molecular sign reading “destroy me”, and then broken down by the proteasome, which is the cell’s recycling center. This catabolism Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Liking, Sharing, and Tweeting to Better Health

BIO2014 Panel

Making an impact online goes beyond having a Facebook page. Helping to open the 2014 BIO International Convention, Amy O’Conner, Director, Digital Government Affairs with Eli Lilly and Company, joined Chief Marketing Officer at POPVOX, Rachna Choudhry; Twitter’s Head of Healthcare, Jeremy Anderson; and Chief Strategist at Pure Communications, Mike Huckman, to discuss how social media can empower individuals and patient advocates to improve the future of health care. O’Conner writes: “Part of what makes Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

The Journey from the Bench to Bedside

shutterstock_2103563

A partnership between a leading academic research center and a biologics company is aiming to develop new therapeutic opportunities Translational research enables therapies get to where they need to be – to the patient. The process is characterized by collaborative activity between university and company scientists. One recent example is the announcement of a three-year collaboration between MedImmune, the global biologics research and development arm of AstraZeneca, and the Clinical and Translational Science Institute (CTSI) Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

From Participant to Judge in the International BioGENEius Challenge

Sagar

My name is Sagar Rambhia, and I participated in the 2011 International BioGENEius Challenge. Three years later, I have come back to be a judge at the 2014 International BioGENEius Challenge. I am 19 years old, and since competing in the 2011 BioGENEius Challenge, I have started my own company and continued to conduct biomedical engineering research. Back in 2011, as part of the BioGENEius Challenge, I was given the life-changing opportunity to present my Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,